A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

June 30, 2010

Study Completion Date

January 31, 2012

Conditions
Asthma
Interventions
BIOLOGICAL

CNTO 3157 or placebo

0.003 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

0.03 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

10 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

0.01 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

1 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

3 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

0.3 mg/kg CNTO 3157 or placebo infusion

BIOLOGICAL

CNTO 3157 or placebo

0.1 mg/kg CNTO 3157 or placebo infusion

Trial Locations (4)

Unknown

Antwerp

Merksem

Berlin

Harrow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY